Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,060 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.
Corrie PG, Marshall A, Dunn JA, Middleton MR, Nathan PD, Gore M, Davidson N, Nicholson S, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Young G, Lorigan P. Corrie PG, et al. Among authors: gore m. Lancet Oncol. 2014 May;15(6):620-30. doi: 10.1016/S1470-2045(14)70110-X. Epub 2014 Apr 15. Lancet Oncol. 2014. PMID: 24745696 Free article. Clinical Trial.
Ipilimumab activity in advanced uveal melanoma.
Khattak MA, Fisher R, Hughes P, Gore M, Larkin J. Khattak MA, et al. Among authors: gore m. Melanoma Res. 2013 Feb;23(1):79-81. doi: 10.1097/CMR.0b013e32835b554f. Melanoma Res. 2013. PMID: 23211837
The cost of ipilimumab toxicity: a single-centre analysis.
Yousaf N, Davidson M, Goode E, Thomas C, Hung R, Gore M, Larkin J. Yousaf N, et al. Among authors: gore m. Melanoma Res. 2015 Jun;25(3):259-64. doi: 10.1097/CMR.0000000000000158. Melanoma Res. 2015. PMID: 25860328
Precision oncology: where next?
Gore M, Larkin J. Gore M, et al. Lancet Oncol. 2015 Dec;16(16):1593-5. doi: 10.1016/S1470-2045(15)00473-8. Lancet Oncol. 2015. PMID: 26678189 No abstract available.
1,060 results